Media Summary: Morepen Labs' management on their recent drug approval, what's driving Jet Airways to record highs and more on Setback for IndiGo, Bank of India under RBI lens, HDFC Bank's mega funding drive and other top stories on What'd You Miss? Hear out views of Eris Lifesciences' management on the Strides acquisition and why is Aberdeen bullish on the rupee on ...
Countdown 20 December 2017 - Detailed Analysis & Overview
Morepen Labs' management on their recent drug approval, what's driving Jet Airways to record highs and more on Setback for IndiGo, Bank of India under RBI lens, HDFC Bank's mega funding drive and other top stories on What'd You Miss? Hear out views of Eris Lifesciences' management on the Strides acquisition and why is Aberdeen bullish on the rupee on ... Find out which brokerage sees 60% upside for ONGC and some levels to watch for the Nifty on All You Need To Know. Indian markets want to celebrate Christmas in style and Accenture's just thrown in the bubbly. Find out more on Morning scare over, the markets are back in the green. Find out which stocks helped the benchmark recover on
Analysing the surge in rice stocks and decoding the prospects for KEC International on Know by when does Dollar Industries plans to achieve Rs 2000 crore revenue target and some hedging bets on exit polls day on ... Where does Star Cement see itself in the years ahead; Ambit Capital's top investment ideas and more on Kamat Hotel's management on the Royal Orchid case, the buzz behind REC and Symphony and more on The management of Aarti Industries on the road ahead, which sectoral index has outperformed all its peers this year and more on ... Know what top dealers in Ahmedabad are making of the exit polls and what's driving the bets on Century Plyboards on ...
Does Jubilant Lifesciences have more upside potential? What is Ambit Asset Management betting on? All this and more on ...
